You are in the accessibility menu

Please use this identifier to cite or link to this item:
Guidelines for the management and treatment of periodic fever syndromes Familial Mediterranean Fever
  • Universidade Federal de São Paulo (UNIFESP)
  • Universidade de São Paulo (USP)
  • Hospital da Criança de Brasília José Alencar (HCB), Brasília, DF, Brasil.
  • Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brasil.
  • Universidade Federal de Pernambuco (UFPE)
  • Universidade Federal do Pará (UFPA)
  • Universidade do Estado do Rio de Janeiro (UERJ)
  • Universidade Federal do Rio de Janeiro (UFRJ)
  • Hospital Pequeno Príncipe, Curitiba, PR, Brasil.
  • Universidade Federal de Minas Gerais (UFMG)
  • Universidade Estadual Paulista (UNESP)
  • To establish guidelines based on scientific evidence for the management of familial Mediterranean fever. The Guideline was prepared from 5 clinical questions that were structured through PICO (Patient, Intervention or indicator, Comparison and Outcome), to search in key primary scientific information databases. After defining the potential studies to support the recommendations, these were graduated considering their strength of evidence and grade of recommendation. 10,341 articles were retrieved and evaluated by title and abstract; from these, 46 articles were selected to support the recommendations. 1. The diagnosis of FMF is based on clinical manifestations, characterized by recurrent febrile episodes associated with abdominal pain, chest or arthritis of large joints; 2. FMF is a genetic disease presenting an autosomal recessive trait, caused by mutation in the MEFV gene; 3. Laboratory tests are not specific, demonstrating high serum levels of inflammatory proteins in the acute phase of the disease, but also often showing high levels even between attacks. SAA serum levels may be especially useful in monitoring the effectiveness of treatment; 4. The therapy of choice is colchicine; this drug has proven effectiveness in preventing acute inflammatory episodes and progression towards amyloidosis in adults; 5. Based on the available information, the use of biological drugs appears to be an alternative for patients with FMF who do not respond or are intolerant to therapy with colchicine.
  • Objetivo Estabelecer diretrizes baseadas em evidências científicas para manejo da febre familiar do Mediterrâneo (FFM). Descrição do método de coleta de evidência A diretriz foi elaborada a partir de 5 questões clínicas que foram estruturadas por meio do PICO (Paciente, Intervenção ou Indicador, Comparação e Outcome), com busca nas principais bases primárias de informação científica. Após definir os estudos potenciais para sustento das recomendações, esses foram graduados pela força da evidência e pelo grau de recomendação. Resultados Foram recuperados, e avaliados pelo título e resumo, 10.341 trabalhos e selecionados 46 artigos para sustentar as recomendações.
Issue Date: 
Revista Brasileira De Reumatologia, 2015.
Elsevier B. V.
  • Autoinflammatory syndromes
  • Childhood
  • Diretrizes
  • Familial mediterranean fever
  • Febre
  • Febre familiar do mediterrâneo
  • Fever
  • Guidelines
  • Infância
  • Síndromes autoinflamatórias
Access Rights: 
Acesso restrito
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.